|
Fibrosis, Liver
|
0.080 |
Biomarker
|
disease |
BEFREE |
The S-index calculated from γ-glutamyl transpeptidase, albumin, and platelets is reported to predict the severity of liver fibrosis.
|
30679923 |
2019 |
|
Fibrosis, Liver
|
0.080 |
Biomarker
|
disease |
BEFREE |
The diagnostic performance of five common non-invasive fibrosis tests for liver fibrosis (stages S2-4), including the aspartate aminotransferase (AST)-to-platelet (PLT) ratio index (APRI), fibrosis index based on 4 factors (FIB-4), King's score, Forns index and gamma-glutamyl transpeptidase (GGT)-to-PLT ratio (GPR), were evaluated for each group.
|
30397608 |
2018 |
|
Fibrosis, Liver
|
0.080 |
Biomarker
|
disease |
BEFREE |
High BMI (OR = 1.369, P < .001), high diastolic blood pressure (OR = 1.048, P < .001), and high gamma glutamyl transpeptidase (OR = 1.018, P = .009) were independent risk factors for liver steatosis among T2DM patients.This study suggested risk factors screening of liver fibrosis and steatosis.
|
30212992 |
2018 |
|
Fibrosis, Liver
|
0.080 |
Biomarker
|
disease |
BEFREE |
Aspartate aminotransferase to platelet ratio index, FIB-4 and gamma-glutamyl transpeptidase to platelet ratio had good diagnostic properties to detect liver fibrosis and cirrhosis in patients with chronic hepatitis B in East Africa.
|
28222249 |
2017 |
|
Fibrosis, Liver
|
0.080 |
Biomarker
|
disease |
BEFREE |
The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
|
28415736 |
2017 |
|
Fibrosis, Liver
|
0.080 |
Biomarker
|
disease |
BEFREE |
Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China.
|
28819319 |
2017 |
|
Fibrosis, Liver
|
0.080 |
Biomarker
|
disease |
BEFREE |
Following a univariate logistic regression analysis, multiple logistic regression analysis indicated that aspartate transaminase (AST) (AUROC = 0.852, cut-off value = 22.5 U/L) serves as an independent predictor of notable liver inflammation, while platelet (PLT) count (AUROC = 0.905, cut-off value = 171.5 ×10<sup>9</sup>/mL) and gamma-glutamyl transpeptidase (GGT) (AUROC = 0.909, cut-off value = 21.5 U/L) level serve as independent predictors of notable liver fibrosis.
|
28487618 |
2017 |
|
Fibrosis, Liver
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Moreover, coreMM was associated with a higher γ-glutamyl transpeptidase level (P=0.026) as well as more severe liver fibrosis (P=0.027) than coreWW, and patients with aa70 substitution (coreMW) were associated with more severe liver steatosis and fibrosis than those without (P=0.020 and P=0.002, respectively).
|
21447872 |
2011 |